Search results
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
WSAU Wausau· 6 days agoBy Blake Brittain (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on...
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
Forbes· 13 hours agoPfizer comfortably beat expectations in its quarterly earnings report Wednesday morning, as the...
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Benzinga via AOL· 2 hours agoWednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling...
GlaxoSmithKline Sues Pfizer and BioNTech Over Covid-19 Vaccine Technology
US News & World Report· 6 days agoUS News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.
Pfizer Earnings Top Views; Boosts Full-Year Guidance
Morningstar· 6 hours agoBy Rob Curran Pfizer posted first-quarter earnings and sales that topped Wall Street targets and boosted its full-year projections as sales of blood thinners and cancer drugs ...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 2 days agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
US opens COVID vaccine to little kids, shots begin next week
AOL· 2 days agoThe U.S. on Saturday opened COVID-19 vaccines to infants, toddlers and preschoolers. The shots will...
What's Going On With Pfizer Stock On Thursday? By Benzinga
Investing.com· 6 days agoWhat's Going On With Pfizer Stock On Thursday?
The images that show the two sides of AstraZeneca’s vaccine ‘miracle’
The Telegraph via Yahoo Finance· 23 hours agoJamie Scott is nothing if not a fighter. He must be to have survived a reaction to his Covid-19 ...
GSK raises forecasts on strong vaccine, HIV drug sales
BioPharma Dive via Yahoo Finance· 5 hours agoSales of the shingles vaccine Shingrix and the RSV shot Arexvy helped fuel quarterly revenue totals...